LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Net Income by Year
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock reported a net loss of $11.2M in fiscal year 2025. This represents a decrease of 145.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $25.4M net loss. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LFMDP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$25.4M | -$11.2M-145.9% | $24.5M+37.4% | $17.8M+139.2% | -$45.5M+25.2% | -$60.9M-3.8% | -$58.6M-1769.4% | -$3.1M-152.8% | -$1.2M-2.9% | -$1.2M-8.9% | -$1.1M-1686.6% | -$62K+86.5% | -$460K-71.7% | -$268K+39.8% | -$446K |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
LFMDP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock financials
Frequently Asked Questions
What was LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's net income in fiscal year 2025?
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock reported a net loss of $11.2M in fiscal year 2025.
How fast is LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's net income growing?
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) net income fell by 145.9% year over year, from $24.5M to -$11.2M in fiscal year 2025.
What is LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's net income over the last twelve months?
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported a $25.4M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's net income changed over the years?
Across the 14 fiscal years this page covers, LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) net income went from -$446K in fiscal year 2012 to -$11.2M in fiscal year 2025.
What was LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock's net income in the most recent quarter?
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported -$7.1M in net income in Q2 2026. This represents a decrease of 337.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported on that line in every period on record.